While radiation therapy is an effective tool to destroy cancer cells, a new study from Vanderbilt researchers suggests that ...
Hosted on MSN
Researchers discover a type of fibroblast that may contribute to the formation and recurrence of overgrown scars
Keloids are raised, overgrown scars that can develop after skin injuries or surgery, often extending beyond the original wound boundaries. For many people, keloids are more than just a cosmetic ...
Fibrosis is the body's way of patching up damage—a bit like fixing a pothole. When skin is cut or a muscle is injured, ...
On Wednesday, FibroBiologics, Inc. (NASDAQ: FBLG) submitted a new patent application with the U.S. Patent and Trademark Office (USPTO). The patent application covers a proprietary fibroblast-derived ...
Morning Overview on MSN
Metabolic enzyme may predict who benefits from cancer immunotherapy
A metabolic enzyme found in the support cells surrounding tumors may hold the key to predicting which cancer patients will ...
FibroBiologics will present on fibroblast-based therapies for chronic diseases at a conference in Freiburg, Germany, on March 27, 2025. FibroBiologics, Inc., a biotechnology company focused on ...
FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Advancing Fibroblast Therapy on Multiple Fronts In the past month, ...
HOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results